Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 67.77 Delayed Data As of 4:10pm ET |  -0.37 / -0.54%Today’s Change | 44.16 Today|||52-Week Range 73.80 | -3.46% Year-to-Date |
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
| Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain Sep 21 / Zacks.com - Paid Partner Content | Why Merrimack Pharmaceuticals Inc Fell 20.3% in August Sep 12 / MotleyFool.com - Paid Partner Content |
| Inside the Recent Surge in Biotech ETFs Sep 14 / Zacks.com - Paid Partner Content |
| 1 month | +6.92% | 3 years | +17.19% | |
| 3 months | +24.85% | 5 years | +27.76% | |
| 1 year | -6.60% | Since inception | +14.67% |
| Previous close | $68.14 |
| Open day’s range | 67.49 – 68.19 |
| Net asset value (NAV) | 68.15 (09/23/2016) |
| Daily volume | 4,054,785 |
| Average volume (3 months) | 6,925,453 |
| XBI | Category | |
|---|---|---|
| Performance 5-yr return | +27.76% | +15.32% |
| Expense Gross exp ratio | 0.35% | 0.48% |
| Risk 5 year sharpe ratio | 0.87 | 1.16 |
| Net assets | $2.1B | $1.1B |
| Average market cap | $4.6B | $37.2B |
| Average P/E | -- | 20.2 |
| Dividend / Share | -- | 0.22% |
| XLV Health Care Select Sector SPDR® Fund |
| RYH Guggenheim S&P 500® Equal Weight Health... |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| Healthcare | 100.00% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
| IONS Ionis Pharmaceuticals Inc | 3.09% |
| MDVN Medivation Inc | 3.04% |
| SRPT Sarepta Therapeutics Inc | 2.96% |
| BIIB Biogen | 2.81% |
| BMRN Biomarin Pharmaceutical Inc | 2.62% |
| ALNY Alnylam Pharmaceuticals Inc | 2.50% |
| AMGN Amgen | 2.49% |
| UTHR United Therapeutics Corp | 2.49% |
| TSRO TESARO Inc | 2.48% |
| BLUE bluebird bio Inc | 2.47% |
